(Q37854080)

24 August 2017

1 reference

title

Role of toll-like receptors in cardiovascular diseases (English)

1 reference

24 August 2017

0 references

cardiovascular disease

1 reference

Jesus G Vallejo

1

1 reference

24 August 2017

language of work or name

English

0 references

publication date

1 July 2011

1 reference

24 August 2017

1 reference

24 August 2017

volume

121

1 reference

24 August 2017

issue

1

1 reference

24 August 2017

page(s)

1-10

1 reference

Toll-like receptors and innate immunity

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1042%2FCS20100539

Toll receptor families: structure and function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100539

A human homologue of the Drosophila Toll protein signals activation of adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100539

Genetic and Physical Mapping of theLpsLocus: Identification of the Toll-4 Receptor as a Candidate Gene in the Critical Region

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100539

Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100539

Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100539

Recognition of single-stranded RNA viruses by Toll-like receptor 7

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100539

Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100539

A Toll-like receptor recognizes bacterial DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100539

Tolerance, danger, and the extended family

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100539

Endocytosed HSP60s use toll-like receptor 2 (TLR2) and TLR4 to activate the toll/interleukin-1 receptor signaling pathway in innate immune cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100539

HSP70 as endogenous stimulus of the Toll/interleukin-1 receptor signal pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100539

Hyaluronan fragments act as an endogenous danger signal by engaging TLR2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100539

Toll-like receptor signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100539

IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100539

The human toll signaling pathway: divergence of nuclear factor kappaB and JNK/SAPK activation upstream of tumor necrosis factor receptor-associated factor 6 (TRAF6)

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100539

Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100539

Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100539

Toll-like receptor 3 is an essential component of the innate stress response in virus-induced cardiac injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100539

CD14-deficient mice are protected against lipopolysaccharide-induced cardiac inflammation and left ventricular dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100539

Immune cell Toll-like receptor 4 is required for cardiac myocyte impairment during endotoxemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100539

Tumor necrosis factor-alpha (TNF-alpha) plays a protective role in acute viralmyocarditis in mice: A study using mice lacking TNF-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100539

The role of inducible nitric oxide synthase in the host response to Coxsackievirus myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100539

The suppressor of cytokine signaling-1 (SOCS1) is a novel therapeutic target for enterovirus-induced cardiac injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100539

Expression of Toll-like receptor 4 is associated with enteroviral replication in human myocarditis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100539

Myeloid differentiation factor-88 plays a crucial role in the pathogenesis of Coxsackievirus B3-induced myocarditis and influences type I interferon production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100539

A critical link between Toll-like receptor 3 and type II interferon signaling pathways in antiviral innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100539

A role for Toll-like receptor 3 variants in host susceptibility to enteroviral myocarditis and dilated cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100539

Mechanisms of the TRIF-induced interferon-stimulated response element and NF-kappaB activation and apoptosis pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100539

Chlamydia pneumoniae--an infectious risk factor for atherosclerosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100539

Acute lower-respiratory-tract infection associated with chlamydial TWAR antibody in Filipino children

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100539

Immunopathogenesis of atherosclerosis: endotoxin accelerates atherosclerosis in rabbits on hypercholesterolemic diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100539

Inflammation and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100539

Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100539

Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100539

Modulation of atherosclerosis in mice by Toll-like receptor 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100539

Increased endothelial expression of Toll-like receptor 2 at sites of disturbed blood flow exacerbates early atherogenic events

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100539

Expansion of circulating Toll-like receptor 4-positive monocytes in patients with acute coronary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100539

Local expression of Toll-like receptor 4 at the site of ruptured plaques in patients with acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100539

Association of the Toll-like receptor 4 gene Asp299Gly polymorphism with acute coronary events.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100539

Variants of toll-like receptor 4 modify the efficacy of statin therapy and the risk of cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100539

Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100539

Toll-like receptor signaling: a critical modulator of cell survival and ischemic injury in the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100539

Role of TLR-2 in the activation of nuclear factor kappaB by oxidative stress in cardiac myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100539

Reduced myocardial ischemia-reperfusion injury in toll-like receptor 4-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100539

Preconditioning with a TLR2 specific ligand increases resistance to cerebral ischemia/reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100539

Innate immunity mediates myocardial preconditioning through Toll-like receptor 2 and TIRAP-dependent signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100539

Preconditioning by toll-like receptor 2 agonist Pam3CSK4 reduces CXCL1-dependent leukocyte recruitment in murine myocardial ischemia/reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100539

Inflammatory mediators and the failing heart: past, present, and the foreseeable future

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100539

Stress-activated cytokines and the heart: from adaptation to maladaptation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100539

Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100539

Toll-like receptor-2 modulates ventricular remodeling after myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100539

Increased toll-like receptor 4 in the myocardium of patients requiring left ventricular assist devices.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100539

Phase 2 trial of eritoran tetrasodium (E5564), a toll-like receptor 4 antagonist, in patients with severe sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100539

Use of sealants and buttressing material in pulmonary surgery: an evidence-based approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100539

Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL).

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100539

TLR4/Asp299Gly, CD14/C-260T, plasma levels of the soluble receptor CD14 and the risk of coronary heart disease: The PRIME Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100539

TLR4 Asp299Gly polymorphism is not associated with coronary artery stenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100539

Toll-like receptor 2 modulates left ventricular function following ischemia-reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100539

Local Overexpression of Toll-Like Receptors at the Vessel Wall Induces Atherosclerotic Lesion Formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100539

In Vivo Expression of Proinflammatory Mediators in the Adult Heart after Endotoxin Administration: The Role of Toll‐Like Receptor–4

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100539

Toll-like Receptor 4 Polymorphisms and Atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20100539

21 January 2018

Identifiers

DOI

10.1042/CS20100539

1 reference

24 August 2017

1 reference